Kirsty Gives Biocon A First Interchangeable US Insulin Aspart Biosimilar

Will Contend With Novo Nordisk’s Novolog And Sanofi’s Merilog Rival

 
• By Dave Wallace
  
Biocon Biologics’ Kirsty is interchangeable with Novolog (Shutterstock)

More from Biosimilars

More from Products